doi:10.1007/s12250-016-3721-9

Andal N, Shanthi P, Krishnan KB, Taralaxmi V, 2003: The epstein barr virus and gastric carcinoma[J]. Indian J Pathol Microbiol, 46, 34-36.
Artero-Castro A, Castellvi J, García A, Hernández J, Ramón y Cajal S, Lleonart ME, 2011: Expression of the ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors[J]. Hum Pathol, 42, 194-203. doi: 10.1016/j.humpath.2010.04.020
Ashkenazi S, Ortenberg R, Besser M, Schachter J, Markel G, 2016: SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells[J]. Oncotarget, , -. doi: 10.18632/oncotarget.7379
Bager P, Wohlfahrt J, Sørensen E, Ullum H, Høgdall C K, Palle C, Husemoen LL, Linneberg A, Kjaer SK, Melbye M, Thyssen JP, 2015: Common filaggrin gene mutations and risk of cervical cancer[J]. Acta Oncol, 54, 217-223. doi: 10.3109/0284186X.2014.973613
Bowers AJ, Boylan JF, 2004: Nek8, a NIMA family kinase member, is overexpressed in primary human breast tumors[J]. Gene, 328, 135-142. doi: 10.1016/j.gene.2003.12.002
Candi E, Schmidt R, Melino G, 2005: The cornified envelope: A model of cell death in the skin[J]. Nat Rev Mol Cell Biol, 6, 328-340. doi: 10.1038/nrm1619
Chang EY, Chang YC, Shun CT, Tien YW, Tsai SH, Hee SW, Chen IJ, Chuang LM, 2016: Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2[J]. PLoS One, 11, e0147390-. doi: 10.1371/journal.pone.0147390
Chang H, Jeung HC, Jung JJ, Kim TS, Rha SY, Chung HC, 2011: Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells[J]. Breast Cancer Res Treat, 125, 55-63. doi: 10.1007/s10549-010-0825-z
Chen H, Ma J, Sunkel B, Luo A, Ding F, Li Y, He H, Zhang S, Xu C, Jin Q, Wang Q, Liu Z, 2013: S100a14: Novel modulator of terminal differentiation in esophageal cancer[J]. Mol Cancer Res, 11, 1542-1553. doi: 10.1158/1541-7786.MCR-13-0317
Cintorino M, Syrjanen S, Leoncini P, Bellizzi De Marco E, Petracca R, Pallini V, Tosi P, Mantyjarvi R, Syrjanen K, 1988: Altered expression of filaggrin in human papillomavirus (HPV) lesions of the uterine cervix[J]. Arch Gynecol Obstet, 241, 235-247. doi: 10.1007/BF00931354
Cooper CD, Liggins AP, Ait-Tahar K, Roncador G, Banham AH, Pulford K, 2006: PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy[J]. Leukemia, 20, 2172-2174. doi: 10.1038/sj.leu.2404424
De Benedetto A, Qualia CM, Baroody FM, Beck LA, 2008: Filaggrin expression in oral, nasal, and esophageal mucosa[J]. J Invest Dermatol, 128, 1594-1597. doi: 10.1038/sj.jid.5701208
Fleming JM, Ginsburg E, Oliver SD, Goldsmith P, Vonderhaar BK, 2012: Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer[J]. BMC Cancer, 12, 266-. doi: 10.1186/1471-2407-12-266
Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K, 1994: Epstein-barr virus-associated gastric carcinoma and epstein-barr virus infection of the stomach[J]. Lab Invest, 71, 73-81.
Garza-Gonzalez E, Bosques-Padilla FJ, El-Omar E, Hold G, Tijerina-Menchaca R, Maldonado-Garza HJ, Perez-Perez GI, 2005: Role of the polymorphic il-1b, il-1rn and tnf-a genes in distal gastric cancer in mexico[J]. Int J Cancer, 114, 237-241. doi: 10.1002/ijc.v114:2
Irvine AD, McLean WH, Leung DY, 2011: Filaggrin mutations associated with skin and allergic diseases[J]. N Engl J Med, 365, 1315-1327. doi: 10.1056/NEJMra1011040
Khan G, Coates PJ, Gupta RK, Kangro HO, Slavin G, 1992: Presence of epstein-barr virus in hodgkin's disease is not exclu-sive to reed-sternberg cells[J]. Am J Pathol, 140, 757-762.
Kim Y1, Choi JW, Lee JH, Kim YS, 2014: Loss of CDC14B expression in clear cell renal cell carcinoma: meta-analysis of microarray data sets[J]. Am J Clin Pathol, 141, 551-558. doi: 10.1309/AJCP4PE4JPSRGBQS
Lara C, Serra V, Marzo C, Valcuende F, Castells A, Bonilla-Musoles F M, 1994: Immunohistochemical localization of filaggrin in benign, premalignant and malignant cervical tissue[J]. Arch Gynecol Obstet, 255, 73-79. doi: 10.1007/BF02391801
Lee MA, Hong YS, Kang JH, Lee KS, You JY, Lee KY, Park CH, 2004: Detection of epstein-barr virus by pcr and expression of lmp1, p53, cd44 in gastric cancer[J]. Korean J Intern Med, 19, 43-47. doi: 10.3904/kjim.2004.19.1.43
Lian YF, Yuan J, Cui Q, Feng QS, Xu M, Bei JX, Zeng YX, Feng L, 2016: Upregulation of KLHDC4 predicts a poor prognosis in human nasopharyngeal carcinoma[J]. PLoS One, 11, e0152820-. doi: 10.1371/journal.pone.0152820
Ling XH, Chen ZY, Luo HW, Liu ZZ, Liang YK, Chen GX, Jiang FN, Zhong WD, 2016: BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression[J]. Oncol Lett. Mar, 11, 2001-2008.
McGlennen RC, Ostrow RS, Carson LF, Stanley MS, Faras AJ, 1991: Expression of cytokine receptors and markers of differentiation in human papillomavirus-infected cervical tissues[J]. Am J Obstet Gynecol, 165, 696-705. doi: 10.1016/0002-9378(91)90312-F
Nagini S, 2012: Carcinoma of the stomach: A review of epide-miology, pathogenesis, molecular genetics and chemoprevention[J]. World J Gastrointest Oncol, 4, 156-169. doi: 10.4251/wjgo.v4.i7.156
Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee S P, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH, 2006: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis[J]. Nat Genet, 38, 441-446. doi: 10.1038/ng1767
Partida-Rodriguez O, Torres J, Flores-Luna L, Camorlinga M, Nieves-Ramirez M, Lazcano E, Perez-Rodriguez M, 2010: Polymorphisms in tnf and hsp-70 show a significant association with gastric cancer and duodenal ulcer[J]. Int J Cancer, 126, 1861-1868.
Rad R, Ballhorn W, Voland P, Eisenacher K, Mages J, Rad L, Ferstl R, Lang R, Wagner H, Schmid RM, Bauer S, Prinz C, Kirschning CJ, Krug A, 2009: Extracellular and intracel-lular pattern recognition receptors cooperate in the recognition of helicobacter pylori[J]. Gastroenterology, 136, 2247-2257. doi: 10.1053/j.gastro.2009.02.066
Rak R, Haklai R, Elad-Tzfadia G, Wolfson HJ, Carmeli S, Kloog Y, 2014: Novel LIMK2 Inhibitor Blocks Panc-1 Tumor Growth in a mouse xenograft model[J]. Oncoscience, 1, 39-48.
Rangel MM, Chaible LM, Nagamine MK, Mennecier G, Cogliati B, de Oliveira KD, Fukumasu H, Sinhorini IL, Mir LM, Dagli ML, 2015: Electroporation transiently decreases GJB2 (connexin 26) expression in B16/BL6 melanoma cell line[J]. J Membr Biol, 248, 47-52. doi: 10.1007/s00232-014-9735-z
Roh SA, Park IJ, Yoon YS, Kwon YH, Chung JH, Kim TW, Cho DH, Lim BH, Kim SK, Kim SY, Kim YS, Kim JC, 2016: Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer[J]. J Cancer Res Clin Oncol, 142, 1705-1714. doi: 10.1007/s00432-016-2177-5
Skaaby T, Husemoen LL, Jorgensen T, Johansen JD, Menne T, Szecsi PB, Stender S, Bager P, Thyssen JP, Linneberg A, 2014: Associations of filaggrin gene loss-of-function variants and human papillomavirus-related cancer and pre-cancer in da-nish adults[J]. PLoS One, 9, e99437-. doi: 10.1371/journal.pone.0099437
Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, Liao H, Evans AT, Goudie DR, Lewis-Jones S, Arseculeratne G, Munro CS, Sergeant A, O'Regan G, Bale S J, Compton JG, DiGiovanna JJ, Presland RB, Fleckman P, McLean WH, 2006: Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris[J]. Nat Genet, 38, 337-342. doi: 10.1038/ng1743
Takada K, 2000: Epstein-barr virus and gastric carcinoma[J]. Mol Pathol, 53, 255-261. doi: 10.1136/mp.53.5.255
Thompson MP, Kurzrock R, 2004: Epstein-barr virus and cancer[J]. Clin Cancer Res, 10, 803-821. doi: 10.1158/1078-0432.CCR-0670-3
Venturutti L, Cordo Russo RI, Rivas MA, Mercogliano MF, Izzo F, Oakley RH, Pereyra MG, De Martino M, Proietti CJ, Yankilevich P, Roa JC, Guzmán P, Cortese E, Allemand DH, Huang TH, Charreau EH, Cidlowski JA, Schillaci R, Elizalde PV, 2016: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1[J]. Oncogene, , -. doi: 10.1038/onc.2016.151
Wang J, Ying Y, Bo S, Li G, Yuan F, 2016: Differentially expressed microRNA-218 modulates the viability of renal cell carcinoma by regulating BCL9[J]. Mol Med Rep, 14, 1829-1834. doi: 10.3892/mmr.2016.5403
Wu J, Lei H, Zhang J, Chen X, Tang C, Wang W, Xu H, Xiao W, Gu W, Wu Y, 2016: Momordin Ic, a new natural SENP1 inhi-bitor, inhibits prostate cancer cell proliferation[J]. Oncotarget, , 10636-. doi: 10.18632/oncotarget.10636
Wu MS, Shun CT, Wu CC, Hsu TY, Lin MT, Chang MC, Wang HP, Lin JT, 2000: Epstein-barr virus-associated gastric carcinomas: Relation to h. Pylori infection and genetic alterations.[J]. Gastroenterology, 118, 1031-1038. doi: 10.1016/S0016-5085(00)70355-6
Wu Y, Peng Y, Wu M, Zhang W, Zhang M, Xie R, Zhang P, Bai Y, Zhao J, Li A, Nan Q, Chen Y, Ren Y, Liu S, Wang J, 2016: Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition[J]. Oncotarget, , -. doi: 10.18632/oncotarget.9457
Xie M, Sun M, Zhu YN, Xia R, Liu YW, Ding J, Ma HW, He XZ, Zhang ZH, Liu ZJ, Liu XH, De W, 2015: Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigene-tically silencing P21/PLK3/DDIT3 expression[J]. Oncotarget, 6, 33587-33601. doi: 10.18632/oncotarget.v6i32
Xu X, Xu L, Gao F, Wang J, Ye J, Zhou M, Zhu Y, Tao L, 2014: Identification of a novel gene fusion (BMX-ARHGAP) in gastric cardia adenocarcinoma[J]. Diagn Pathol, 9, 218-. doi: 10.1186/s13000-014-0218-4
Zang WQ, Yang X, Wang T, Wang YY, Du YW, Chen XN, Li M, Zhao GQ, 2015: MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1[J]. World J Gastroenterol, 21, 5867-5876. doi: 10.3748/wjg.v21.i19.5867
Zhang W, Liu H, Liu Z, Zhu D, Amos CI, Fang S, Lee JE, Wei Q, 2015: Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma[J]. Cancer Epidemiol Biomarkers Prev., 24, 1101-1110. doi: 10.1158/1055-9965.EPI-14-1380-T
Zhang Y, Tian Y, Yu JJ, He J, Luo J, Zhang S, Tang CE, Tao YM, 2013: Overexpression of WDR62 is associated with centrosome amplification in human ovarian cancer[J]. J Ovarian Res, 6, 55-. doi: 10.1186/1757-2215-6-55
Zhao D, Liu S, Sun L, Zhao Z, Liu S, Kuang X, Shu J, Luo B, 2016: Glypican-4 gene polymorphism (rs1048369) and suscep-tibility to Epstein-Barr virus-associated and -negative gastric carcinoma[J]. Virus Res, 220, 52-56. doi: 10.1016/j.virusres.2016.04.005
Zhao N, Yang K, Yang G, Chen D, Tang H, Zhao D, Zhao C, 2013: Aberrant expression of clock gene period1 and its correlations with the growth, proliferation and metastasis of buccal squamous cell carcinoma[J]. PLoS One, 8, e55894-. doi: 10.1371/journal.pone.0055894
Zheng L, Sun D, Fan W, Zhang Z, Li Q, Jiang T, 2015: Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer[J]. PLoS One, 10, e0118276-. doi: 10.1371/journal.pone.0118276